OBJECTIVE: To explore the relationship between hypercholesterolaemia, age and BMI among females and males. DESIGN: Population-based cross-sectional survey. SUBJECTS: The data came from the initial surveys of the WHO MONICA Project. In all, 27 populations with 48 283 subjects (24 017 males and 24 266 females) aged 25-64 y were used for the analysis. MEASUREMENTS: Total cholesterol, weight, height, BMI, prevalence of hypercholesterolaemia (PHC) defined as cholesterol Z6.5 mmol/l, and the prevalence of obesity (POB) defined as BMI Z30 kg/m 2 . RESULTS: PHC increased with age, with PHC in males being significantly higher than in females at age range 25-49 y and significantly lower than in females at age range 50-64 y. Age-related increase in hypercholesterolaemia was steeper in females than in males. There was a statistically significant positive association between hypercholesterolaemia and BMI. Multiple logistic regression analysis revealed a negative statistically significant (Po0.001) effect modification involving age and BMI on the risk of having hypercholesterolaemia both in females and males. The relation between PHC and BMI became weaker in higher age groups, with no statistically significant association in females aged 50-64 y. CONCLUSION: Public health measures should be directed at the prevention of obesity in young adults since the strongest effect of obesity on the risk of hypercholesterolaemia has been found in subjects aged 25-39 y.
Introduction
Although there has recently been a decreasing trend in mortality from coronary heart disease (CHD) in the majority of industrialised countries, CHD remains a major health problem worldwide. 1, 2 Moreover, elevated blood cholesterol is still an important risk factor for CHD. [3] [4] [5] It has been demonstrated by cross-sectional and most of the longitudinal studies that among adults, blood cholesterol concentration increases with age. [6] [7] [8] All available results also suggest that the increase in total cholesterol with age is different for men and women. 9 In addition, there is a general consensus that the total cholesterol level rises as the body mass index rises. [10] [11] [12] On the other hand, several studies have failed to detect the relation between BMI and cholesterol. [13] [14] [15] [16] Moreover, in the literature there is a widespread opinion that the reduction of BMI among older persons will automatically lead to a decrease in cholesterol level. 17 There have not been published reports regarding an explicit examination of the relationship between total cholesterol and age, body mass index and a potential interaction term involving age and BMI. Schulte et al 18 have examined the cholesterol-age relationship in an analysis stratified by gender. The assessment of the modifying effect of age on the cholesterol-body mass index relation has been disregarded. The main objective of the present paper was therefore to explore specifically the cholesterol-age and body mass index relationship in an analysis stratified by gender, using the initial survey data from the WHO MONICA Project. The present analysis sought as well to estimate the magnitude of the potential modifying effect of age on the cholesterol-BMI association taking into consideration gender differences.
Methods
The WHO Multinational Monitoring of Trends and Determinants in Cardiovascular Disease (MONICA) Project is a study that was initiated in the early 1980s 19 with the main objective of assessing the extent to which trends in coronary heart disease and cerebrovascular disease are related to changes in known risk factors, daily living habits, health care, or major socioeconomic features in defined communities in different countries. An extensive detailed description of the sampling and survey procedures is given in the MONICA Manual. 20, 21 A representative sample of subjects aged 35-64 y in each study population was collected, although some MONICA collaborating centres (MCCs) included the 25-34 y age group as well. The individuals selected were invited to attend a clinical examination and to provide questionnaire data about their sociodemographic characteristics and lifestyle habits according to a standardised protocol.
Variables
Blood lipids. A venous blood sample was drawn with the subject in sitting position, with limited use of a tourniquet. It was recommended that total cholesterol be determined on the day of blood collection. If not, samples after centrifugation were stored at 41C for up to 4 days, or if longer storage was necessary, immediately frozen at À201C or lower. The enzymatic method was recommended and used in most studied populations. A description of sample collection, storage, preparation, analytical procedures and quality assessment of cholesterol has been given in more detail elsewhere. 22, 23 Hypercholesterolaemia was defined as total cholesterol Z6.5 mmol/l. There is a widespread consensus that at this cholesterol level, the risk of developing CHD is substantially increased.
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Body mass index (BMI). Body height and weight were measured according to a standardised protocol with participants standing without shoes and heavy outer garments. 25 Body mass index (BMI) was calculated as weight in kilograms divided by the square of the height in metres (kg/m 2 Age. Age was considered to be a categorical variable grouped in to eight 5-y age classes. The subjects were allocated to the age classes according to the actual age on the day of clinical examination.
Data Analysis
We used data from the initial surveys of the WHO MONICA Project that were carried out between 1979 and 1989. The analysis was restricted to populations where the whole age range (ie 25-64 y) was covered. 27 Moreover, MCCs with an unacceptable External Quality Assessment Score for cholesterol and/or weight and height measurement 23, 25 were excluded from the analysis. Consequently, the analysis was performed on pooled data from 27 populations in 21 MCCs representing 15 countries. Table 1 summarises the information about the populations and number of subjects used for the analysis.
In the first stage of the analysis, prevalence of hypercholesterolaemia (PHC) and prevalence of obesity (POB) (in %) were calculated by age and gender on the pooled data from all centres. In each age group, gender differences in PHC and POB were tested for their statistical significance by Effect of age on the cholesterol-BMI relation in males and females M Gostynski et al logistic model while adjusting for populations. Age-and gender-specific PHC was also determined separately for the three BMI classes. In the second stage, the associations were modelled using a logistic model with hypercholesterolaemia as the dependent variable. Age group and BMI class were the independent variables, and the population was considered as a random effect. Because of the remarkable gender differences observed in the first stage of the analysis, the model was fitted separately for men and women. The analysis was carried out using the SPSS statistical package version 9.
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Results
The population means values of the studied variables were as follows: total cholesterol 5. PHC increased with age in both male and female subjects ( Table 2) . A substantially steeper age-related PHC increase was seen among females (eg 550% increase in PHC from 25-29 to 60-64 y) than men (218% increase from the first to the last age group), with the PHC values for females being statistically significantly lower than for males at age 25-49 y and statistically significantly higher than males at age 50-64 y. Moreover, PHC increased in men to a great extent from age 25-29 to age 35-39 y (136% increase in PHC), with almost no rise from age 40-44 to age 60-64 y (17% increase). On the other hand, in young women aged 25-39 y increase in PHC was weak, and it accelerated noticeably among women who were 40-64 y old (50 vs 225% increase in PHC).
POB increased with age of subject ( Figures 1 and 2 ). The effect of age on POB was similar to that on PHC. Again, POB increased remarkably more steeply among females (an approximately 480% rise in POB from the first to the last age group) compared to males (180% increase over the same age range), with the lower POB among young women and higher in older ones, as compared to the corresponding agespecific POB in males. Table 3 presents the distribution of PHC according to age and BMI separately for males and females. From this, three findings seem to be of interest. Firstly, the increase in PHC with advancing age had a remarkably different pattern The multiple logistic regression analysis confirmed, what was anticipated from the descriptive analysis. Both in males and females there was a strong negative interaction between age and BMI on the risk of having hypercholesterolaemia (Po0.001). The estimated odds ratios from the model, with normal weight subjects aged 25À29 y as the reference, are shown in Table 4 . To illustrate the age-BMI interaction on the risk of having hypercholesterolaemia, the logistic regression analysis were repeated separately for each age group, with BMI class as the independent variable ( There has been much debate on whether the age-related cholesterol increase is the result of a natural process of intrinsic ageing (eg greater susceptibility of older people to the effect of dietary cholesterol) or whether it is due to Effect of age on the cholesterol-BMI relation in males and females M Gostynski et al age-associated anthropometrics and/or lifestyle changes. Grundy et al 31 reported that both increasing production rates of LDL and decreasing fractional clearance rates of LDL are responsible for the rise in blood cholesterol levels with age. The results also suggest that fractional clearance rates are more influential at lower LDL concentrations and production rates are more influential at higher LDL concentrations. These observations might have explained the direct mechanism of rising cholesterol levels with age, but it is still unclear whether this mechanism is modifiable, and how it may be influenced by lifestyle. For example, several non-Western communities have been described in which the plasma LDL concentration seems not to increase with age. [32] [33] [34] Total cholesterol is on average also very low in these populations. Such results raise the possibility that a decline in LDL receptor activity might not be an inevitable consequence of ageing, but might rather result from an interaction between age and an environmental factor or element of lifestyle, and hence be potentially modifiable. In fact, there is some evidence that even in Western community with rather high total cholesterol level, diet and dietary population-based intervention might successfully modify the cholesterol-age relation. As Jousilahti et al 35 have
reported, cholesterol level did not increase with age in any one birth cohort in the middle-aged population of Eastern Finland.
The present analysis has also revealed a strong positive association between PHC and BMI. This finding corresponds well with the observations made in other cross-sectional studies such as, for example, the LRC Program Prevalence Study. 6 However, several studies have failed to detect the relation between BMI and cholesterol. [13] [14] [15] [16] Obesity is a chronic condition that results of an interaction between genetic and environmental factors. 36 Various lipid abnormalities have been observed in obese subjects, including elevated total cholesterol, triglycerides and lower highdensity lipoprotein cholesterol levels. 37 The dyslipidaemia among the obese subjects might on one hand be due to an increased intake of food rich in saturated fatty acids and cholesterol. 38 On the other hand, to an increased basal cholesterol synthesis and to a decrease in LDL-induced inhibition of endogenous cholesterol synthesis through disturbing activity of 3-hydroxy-3-methylglutarate-coenyzme A. 39 However, the latter was found only in obese subjects with hypercholesterolaemia. In individuals with simple obesity or hypercholesterolaemia, without obesity, alteration of cholesterol synthesis through this pathway was not observed. Moreover, subjects with established obesity have an increased lipogenesis in hepatocytes (not in adipocytes) that might contribute to develop and/or maintain the excessive fat mass 40 and, together with hyperinsulinaemia, might additionally alter lipid homeostasis by promoting cholesterol synthesis. 41 However, the prevalence of high blood cholesterol and mean levels of cholesterol do not increase consistently with increasing BMI above 25 kg/ m 2 . 11 This phenomenon was also seen in our descriptive analysis where the effect of BMI on PHC values varies according to BMI range, with a greater increase in PHC between first (normal) and second (overweight) BMI classes than between first and third (obese) BMI classes (data not shown). Additionally, the effect of BMI on PHC varies substantially according to age as well as gender. The strongest BMI-related increase in PHC values has been found in males at age 25-39 y and in females at age 25-34 y, when the cholesterol levels are still relatively low. On the other hand, in females at the age of 50-64 y where the cholesterol levels are already quite high, there is no statistically significant correlation between PHC and BMI, and among males is this PHC-BMI relation weak. The same relationship was observed by Eberle et al. 42 Tanaka et al 43 reported that among malesFbut not among femalesFthere was a significant association between BMI and coronary stenosis, and this positive association was more pronounced among younger patients than older ones. Thus, this clinical finding is consistent with the result of our analysis indicating the presence of interaction effects of age and indirectly of gender on PHC-BMI relation. It should be stressed that our study samples were population based, so that one can expect that health problems were much more common in the older subjects than in the younger ones. Health status could be then a confounder of the interaction effects of age on PHC-BMI relation. Unfortunately, we do not have data on health status of our subjects. Nevertheless, failure to consider age and gender modifying effects on cholesterol-BMI relation may induce bias, and may therefore lead to misleading conclusions making results from population studies incomparable.
As our bivariate analysis shows between the ages of 25 and 49 y, males have statistically significantly higher PHC than females, and PHC increases more steeply over this age group among males than among females. On the other hand, after the age of 49 y the magnitude of the age-related increase in PHC reduces gradually in men and speeds up among women throughout the whole age range studied, that is, up to 64 y. In the analysis stratified by age and BMI, we have found that in overweight or obese males PHC increased by age substantially less steeply than in males in the BMI category of o25 kg/m 2 . On the other hand, the age-related rise in PHC in females was steeper and of similar intensity in all three BMI groups. The different course of gender-specific PHC by age might be caused by oestrogen deficiency in postmenopausal women. It has been extensively described that menopause is highly associated with an unfavourable lipid profile. 44 The mechanisms by which oestrogen deficiency affects the cholesterol level seem to be mediated through alterations in the lipid-lipoprotein profile 45 and changes in the distribution of fat mass towards a more android distribution. 46 However, weight increase does not seem to be related to the menopause, as weight increase in women was similar whether they had gone through the menopause or not. 47 Tremollieres et al 48 found that about 30% of postmenopausal women had serum total cholesterol
Effect of age on the cholesterol-BMI relation in males and females M Gostynski et al levels above 250 mg/dl associated with LDL cholesterol above 160 mg/dl. Moreover, this higher prevalence of hypercholesterolaemia in postmenopausal women was also found in women aged 45-55 y, suggesting an effect of menopause rather than of age. Multivariate analysis also indicated that this effect was independent of BMI and years since menopause, and thus strongly supported the role of oestrogen deficiency in these unfavourable alterations. In our study, the impact of BMI on the risk of having hypercholesterolaemia becomes weaker among subjects aged 50-64 y, especially in females. This result seems to be in accordance with the finding that postmenopausal women of normal weight who became overweight or obese 5 y later did not show any deterioration in their risk factors due to weight change. 47 This study has some limitations. Firstly, it is cross-sectional in nature. Thus, the different age-related increase in PHC in males and in females might have been biased by a survival effect. Since the duration of the risk factors, and not solely their severity, predict the development of disease in question, 49 an elevated level of total cholesterol among males aged 25-34 y might thus have led to premature coronary heart disease and consequently to premature death from it around the age of 50 y. Thus, the premature death due to coronary heart disease might partially explain the observed differences in distribution of PHC among males and females according to age. Some differences seem, however, to arise from gender-specific factors. Secondly, in the present analysis we used BMI, which does not describe body fat distribution. 50 It has been shown that waist circumference, hip circumference and in particular waist-hip ratioFthe indicators of abdominal obesityFare positively correlated with blood lipid parameters and they are associated with increased risk of mortality from CHD independently of BMI. 51 This excess risk seems to be due to metabolic alterations caused by intra-abdominal fat deposits. 52 However, this positive associationFin particular with plasma cholesterolFis only present in the upper quartile of the BMI distribution, indicating that obesity is necessary for these relationships to exist. 53 Additionally BMI is stronger related to waist circumference and, to a lesser extent, to waist-hip ratio. 54 It must be pointed out that, unlike most previous studies, Tanaka et al 43 failed to detect a positive association between waist-hip ratio and significant coronary stenosis both in males and in females. Thirdly, the multicentre population studies commonly encounter the problem of quality measurement. In the MONICA Project, the possible sources of methodological differences regarding cholesterol measurement were carefully evaluated, revealing poor quality of cholesterol measurements in some populations. Populations with unacceptable quality score were, however, excluded from the present analysis. Regarding the accuracy of measurement of weight and height, relatively few problems were observed 25 and they might be neglected.
Finally, we used the fixed cutoff points for definition of hypercholesterolaemia and obesity. It is unlikely that other cutoff points would have altered the direction of the observed association. Despite these limitations, one main advantage of the present study is that it includes data from numerous populations in different countries, and the results therefore are broadly representative. All data were collected using standardised survey procedures and methods, and each step of data collation as well as data preparation were carefully evaluated. Finally, our analysis describes 'natural' relationships between the studied variables as in the 1980 s there were likely to be fewer potential confounding factors compared to the current epidemiological situation in the populations.
Based on the results of our analysis it might be emphasised that public health measures should be vigorously directed at the prevention of obesity in young adults since the strongest effect of obesity on the risk of hypercholesterolaemia has been found in subjects aged 25-39 y.
